Biorepositories Session Spotlight: Meeting the Biospecimen Management Challenges of the Coming Decade and Beyond

The end goal for any organization working in biopharmaceuticals is to maintain high quality biospecimens for research, clinical trials and patient diagnosis. While a great deal of progress has been made in the last decade in biospecimen management, there is still a ways to go, especially as new technologies emerge and the biopharma industry tries to standardize their processes. In today's featured session, keynote Helen Moore, Program Director for NCI’s Biorepositories and Biospecimen Research Branch discusses this and other challenges such as new understandings about patient de-identification and informed consent and building robust systems for management of biospecimen lifecycle data.

The Biorepositories and Sample Management Conference will take place September 25-27, 2013 in Boston, MA.  For more information on this session and the rest of the program, download the agenda.  If you'd like to join us in Boston, as a reader of this blog when you register to join us and mention code XP1898BLOG, you'll save 15% off the standard rate.

Keynote Helen Moore

Featured Session:  Meeting the Biospecimen Management Challenges of the Coming Decade and Beyond

Featured Speaker: Helen Moore, Program Director, NCI-BBRB

About the session: A great deal of progress has been made over the last decade in biospecimen management. However, significant challenges remain and must be addressed in order to ensure that high quality biospecimens are available for research, clinical trials, and patient diagnosis.

• • Incorporating new understandings about patient deidentification and informed consent into biospecimen management practices
• • Building the foundation of knowledge in Biospecimen Science
• • Applying new knowledge to the development of common biospecimen management standards
• • Building robust systems for management of biospecimen lifecycle data and donor clinical data

Share this article with your social network, just click below to share now!

Share |